These compounds may interact with:
Estradiol 17-beta-dehydrogenase 2
Potentially involved in: carcinoma; endometriosis; hypoactive sexual desire disorder; endometrial neoplasms; liver cirrhosis, experimental; active crohn's disease; atypical teratoid / rhabdoid tumor; breast cancer; breast carcinoma; colon cancer; cystic fibrosis; esophageal adenocarcinoma; malignant mesothelioma; medulloblastoma, large-cell; ovarian cancer; pancreatic cancer; primary pancreatic ductal adenocarcinoma; psoriasis; ulcerative colitis
Disease data sourced from Pharos.